Mutant IDH is frequent in LGGs but also detected in 50–88% of secondary glioblastomas and in 5% of primary glioblastomas, resulting in altered 2-hydroxyglutarate production and altered DNA methylation [4,22,23]. The gene discussed is IDH1; the disease is glioblastoma.